Company Overview of Neothetics, Inc.
Neothetics, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutics addressing lifestyle and medical indications in aesthetic medicine and ophthalmology. It offers LIPO-202, an injectable formulation of the long-acting ß2-adrenergic receptor agonist for the treatment of symptomatic exophthalmos (protrusion of the eye from the orbit) associated with thyroid-related eye disease; and LIPO-102, an injectable combination of salmeterol xinafoate and the glucocorticoid fluticasone propionate to reduce the volume of orbital fat and the resultant exophthalmos in thyroid-related eye disease. Neothetics, Inc. was formerly known as Lithera, Inc. and changed its name to Neothetics,...
9191 Towne Centre Drive
San Diego, CA 92122
Founded in 2007
Key Executives for Neothetics, Inc.
Vice President of Pharmaceutical Development & Manufacturing
Board Observer and Director
Compensation as of Fiscal Year 2014.
Neothetics, Inc. Key Developments
Lithera, Inc. has Changed its Name to Neothetics, Inc
Aug 12 14
On August 12, 2014, Lithera, Inc. changed its name to Neothetics, Inc.
Lithera, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-09-2014 08:40 AM
Mar 19 14
Lithera, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-09-2014 08:40 AM. Venue: The Westin Grand Central Hotel, New York, New York, United States. Speakers: George W. Mahaffey, Chief Executive Officer, President and Director.
Lithera, Inc. Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-04-2014 10:00 AM
Feb 27 14
Lithera, Inc. Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-04-2014 10:00 AM. Venue: Marriott Copley Place Hotel, Boston, Massachusetts, United States. Speakers: George W. Mahaffey, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|